Abstract

Measles elimination in Europe is hindered by recurrent outbreaks, typically in non-immunised specific sub-populations. In 2003 and 2004, two measles outbreaks occurred in Jewish ultra-orthodox communities in Jerusalem, Israel. In 2007, another measles outbreak emerged in Jerusalem. Epidemiological investigation and control activities were initiated. Three measles cases (15 years old, 22 years old and an infant; all unvaccinated) were diagnosed in Jerusalem in August 2007. All three belonged to Jewish ultra-orthodox communities in London, United Kingdom, and had had contact with patients in London. The epidemiological investigation did not reveal any connection between these cases other than their place of origin. The disease spread rapidly in extremely ultra-orthodox sub-groups in Jerusalem. Until 8 January 2008, 491 cases were reported. Most patients (70%) were young children (0-14 years old), 96% unimmunized. Frequently, all the children in a large family were infected; two thirds of the cases belonged to family clusters of more than two patients per family (in part due to non-compliance with post-exposure prophylaxis recommendations). The high age-specific incidence among infants 0-1-year- (408.5/100,000) and 1-4-year-olds (264.1/100,000) is a cause for concern. The hospitalisation rate was 15% (71/491), mainly due to fever, patients (26.7%) presented with pneumonitis or pneumonia and two patients presented with encephalitis. There have not been any deaths to date. The outbreak was apparently caused by measles importation into unprotected groups. Despite a high national immunisation coverage (94-95%), programmes to increase and maintain immunisation coverage are essential, with special focus on specific sub-populations.

Highlights

  • Measles presents a major global disease burden and is still the number one killer among vaccine-preventable diseases, causing almost half a million deaths a year [1,2,3]

  • Kremer et al described the measles virus genotypes in Europe during 2005 and 2006 as being mainly D4, D6 and B3 [9]; the largest outbreaks considered in that paper happened in the Ukraine, Romania, Germany and the Russian Federation

  • The past five years have seen a plethora of reports on measles outbreaks from different countries and geographic regions throughout Europe

Read more

Summary

Introduction

Measles presents a major global disease burden and is still the number one killer among vaccine-preventable diseases, causing almost half a million deaths a year [1,2,3]. Measles elimination in Europe is hindered by recurrent outbreaks, typically in non-immunised sub-populations. In 1999 and 2000, such an outbreak was reported in the Netherlands, with three measles-related deaths and 68 hospitalisations among 2,961 cases; 84 percent of the cases (2,317 people) were eligible for vaccination, but were not vaccinated for religious reasons [4]. The nomad Roma/Sinti population has been associated with the spread of measles in several regions of Europe [8,9]. Kremer et al described the measles virus genotypes in Europe during 2005 and 2006 as being mainly D4, D6 and B3 [9]; the largest outbreaks considered in that paper happened in the Ukraine, Romania, Germany and the Russian Federation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call